Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-062163

Director acquired 2,909,091 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BioLexis Pte Ltd. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-23 Exercise or conversion : show line 1 in the form +2,909,091 $0.23 $674,909 16,948,585 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-23 Exercise or conversion : show line 2 in the form Warrant (Right to Buy) −3,636,364 0 D
Loading xslF345X03/doc4.xml…